The endoplasmic reticulum based complex Bcl-B/IP3R1 as a new target for cancer therapy

assignment_turned_inprojectUntil30 Sep 2022Closed

Funder: Institut National du CancerProject code: INCa-DGOS-13231 Call for proposal: TRANSLA18

Funded under: TRANSLA

The endoplasmic reticulum based complex Bcl-B/IP3R1 as a new target for cancer therapy

- Summary
- DMPs

Partners

INSB , University of Nantes , INSERM U1065 , Centre Hospitalier Universitaire d'Angers , CHU , Université Denis Diderot Paris 7 , Centre Hospitalier Universitaire de Nice , CNRS , INSERM 1052 - Centre Léon Bérard , Centre Léon Bérard , INSERM , ICO , University of Angers , CRCNA

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::138b99ed718fe66a87045b1e202e09a1&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

The endoplasmic reticulum based complex Bcl-B/IP3R1 as a new target for cancer therapy

The endoplasmic reticulum based complex Bcl-B/IP3R1 as a new target for cancer therapy

Loading